In this regard, presence of BRAF V600E mutation in lymphatic exudate-derived EVs after lymphadenectomy was indicative of fast disease progression (García-Silva et al., 2019), suggesting their use as a highly sensitive method for detection of minimal residual disease in melanoma at early stages. The gene discussed is BRAF; the disease is melanoma.